Lv41
540 积分 2022-05-19 加入
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors
27天前
已完结
The Emerging Toxicity Profiles of Anti–CTLA-4 Antibodies Across Clinical Indications
1个月前
已完结
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
1个月前
已完结
Advances and challenges in cancer immunotherapy: Strategies for personalized treatment
1个月前
已完结
The Impact of Molecular Subtype on Efficacy of Chemotherapy and Checkpoint Inhibition in Advanced Gastric Cancer
2个月前
已关闭
Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open‐label, controlled trial
10个月前
已完结
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
11个月前
已关闭
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
11个月前
已完结
Drug-Drug Interactions with Glucagon-Like Peptide-1 Receptor Agonists
11个月前
已完结
Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial
11个月前
已完结
皖公网安备34019202002308
